The guide RNA brings the catalytically modified Cas protein to a complementary DNA sequence, where it positions the deaminase near the intended base. The deaminase then enables the relevant cytosine-to-thymine or adenine-to-guanine conversion. Because this mechanism avoids a double-strand DNA break, efficiency reflects how successfully the components produce the desired substitution at the target site.
Performance can change with the editor design, guide sequence, genomic location, delivery method, and cell type. These variables influence whether the editing components reach the target and position the deaminase effectively. Consequently, an editor that performs well at one site or in one cellular setting may produce a different proportion of intended changes elsewhere.
Bystander edits are additional base changes that occur near the intended target and can complicate performance assessment. A high proportion of edited molecules does not necessarily indicate a desirable outcome if many carry unintended accompanying changes. Researchers therefore need to distinguish the intended substitution from nearby bystander changes when evaluating precision and experimental success.
Evaluation should separate molecules carrying the desired base conversion from those containing other changes at the target site. The resulting proportion of intended substitutions provides the efficiency measure, while the presence of bystander edits adds important context about precision. This distinction helps researchers compare editor and guide configurations and identify conditions that require optimization.
Optimization can focus on the choice of editor, guide sequence, genomic location, delivery method, and cell type. These factors should be considered together because changing one may alter the outcome produced by the others. Comparing results across such conditions helps identify a configuration that increases intended changes while providing a clearer assessment of bystander effects.
The measure is useful when researchers need to optimize targeted sequence changes for functional genomics, disease modeling, or potential therapeutic development. In functional studies, it helps assess whether the intended substitution was produced sufficiently to investigate its consequences. For disease-related or therapeutic work, it also provides information about performance and the precision of the resulting edits.